Department of Rheumatology of The First Hospital and Institute of Innovation and Applied Research in Chinese Medicine, Hunan University of Chinese Medicine, Changsha, Hunan, China.
Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, Hunan, China.
Front Immunol. 2023 Oct 26;14:1272133. doi: 10.3389/fimmu.2023.1272133. eCollection 2023.
Angiogenesis plays a key role in the pathological process of inflammation and invasion of the synovium, and primarily drives the progression of rheumatoid arthritis (RA). Recent studies have demonstrated that the Notch signaling may represent a new therapeutic target of RA. Although the Notch signaling has been implicated in the M1 polarization of macrophages and the differentiation of lymphocytes, little is known about its role in angiogenesis in RA. In this review, we discourse the unique roles of stromal cells and adipokines in the angiogenic progression of RA, and investigate how epigenetic regulation of the Notch signaling influences angiogenesis in RA. We also discuss the interaction of the Notch-HIF signaling in RA's angiogenesis and the potential strategies targeting the Notch signaling to improve the treatment outcomes of RA. Taken together, we further suggest new insights into future research regarding the challenges in the therapeutic strategies of RA.
血管生成在滑膜炎症和侵袭的病理过程中起着关键作用,并主要驱动类风湿关节炎(RA)的进展。最近的研究表明,Notch 信号可能代表 RA 的一个新的治疗靶点。虽然 Notch 信号已被牵涉到巨噬细胞的 M1 极化和淋巴细胞的分化中,但关于其在 RA 中的血管生成作用知之甚少。在这篇综述中,我们讨论了基质细胞和脂肪因子在 RA 血管生成进展中的独特作用,并研究了 Notch 信号的表观遗传调控如何影响 RA 中的血管生成。我们还讨论了 Notch-HIF 信号在 RA 血管生成中的相互作用以及针对 Notch 信号的潜在治疗策略,以改善 RA 的治疗效果。总之,我们对 RA 治疗策略中的挑战的未来研究提出了新的见解。